Savara Inc (SVRA)
Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in December 1995 and is headquartered in Langhorne, PA.
Address
6836 BEE CAVE ROAD
AUSTIN, TX 78746
Founded
1995
Number of Employees
37
Website
http://www.savarapharma.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)